about
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitisAquaporin-4 antibodies are not related to HTLV-1 associated myelopathyImpact of pregabalin treatment on synaptic plasticity and glial reactivity during the course of experimental autoimmune encephalomyelitis.Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE.The suppressive effect of IL-27 on encephalitogenic Th17 cells induced by multiwalled carbon nanotubes reduces the severity of experimental autoimmune encephalomyelitis.Granulocyte-colony-stimulating factor treatment enhances Foxp3(+) T lymphocytes and modifies the proinflammatory response in experimental autoimmune neuritis.Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubes.Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease.Serum BDNF levels are not reliable correlates of neurodegeneration in MS patients.A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. The role of plasmacytoid dendritic cells and B lymphocytesDimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: Implications for the treatment of multiple sclerosisClinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS
P50
Q28533957-8F6CC46C-5DCF-423F-935B-72763B2CCB07Q28727305-A69CBA27-0268-40AD-B98D-9767E25ABEA1Q34259055-FE66FAD8-2408-458B-BA3E-0A19035F7115Q34319492-66D2AC53-3CCF-4A28-B026-7748FAB72F47Q39012296-13B05A00-AA61-4BA1-914D-1233DD20653BQ40494804-C80CEC05-0AB3-48EC-B709-40234016DE6DQ43638406-4C085FA0-03BA-4150-B474-40C6F2662DE4Q44366891-6D08A25E-CF26-4254-8A73-D529FA6B32FAQ45334041-060A9080-0D15-498C-8F99-1FC5FAB10D5FQ46411376-4ACE7A9A-8B06-47AA-8F64-2FD794706EF2Q47642585-E5AA3908-2D35-425C-B5BB-92185DBD1958Q48274057-CB5CB2B9-441F-42F2-974E-CC55CA2D1533Q53226836-062232D4-C349-425A-8297-64D16B593AE6Q88083741-80397314-86CA-47E2-8F73-F71B5DE03B87Q88680202-3AADAD41-2681-4584-802D-5CC1999970FAQ91651173-B97D6FD6-3670-4A67-B574-B26DA5F8ED5E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adriel Santos Moraes
@ast
Adriel Santos Moraes
@en
Adriel Santos Moraes
@es
Adriel Santos Moraes
@nl
type
label
Adriel Santos Moraes
@ast
Adriel Santos Moraes
@en
Adriel Santos Moraes
@es
Adriel Santos Moraes
@nl
prefLabel
Adriel Santos Moraes
@ast
Adriel Santos Moraes
@en
Adriel Santos Moraes
@es
Adriel Santos Moraes
@nl
P106
P31
P496
0000-0002-9365-573X